(Q47574722)

4 February 2018

editorial

0 references

title

Antibodies against RAGE in sepsis and inflammation: implications for therapy (English)

1 reference

4 February 2018

1 reference

1 reference

Emily C Lutterloh

1

1 reference

4 February 2018

Steven M Opal

series ordinal

2

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 June 2007

1 reference

4 February 2018

Expert Opinion on Pharmacotherapy

published in

1 reference

4 February 2018

volume

8

1 reference

4 February 2018

issue

9

1 reference

4 February 2018

page(s)

1193-1196

1 reference

4 February 2018

Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trial.

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

HMG-1 as a late mediator of endotoxin lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

High mobility group 1 B-box mediates activation of human endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

In silico design of clinical trials: a method coming of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

The dynamics of acute inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

In silico models of acute inflammation in animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1193

10.1517/14656566.8.9.1193

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018